The landscape of malignancy treatment is constantly evolving, with a growing emphasis on identifying novel therapeutic targets Anti Cancer Medicines for drug development. Traditional therapies often target rapidly dividing cells, leading to significant side consequences. However, the emergence of sophisticated genomic profiling techniques has alter